Actinic keratosis is not cancer, but it’s not entirely harmless either. It’s classified as a precancerous lesion, meaning it has the potential to develop into squamous cell carcinoma, the second most common type of skin cancer. Roughly 1% to 10% of actinic keratoses make that progression, and for those that do, the timeline averages about two years.
Why the Line Between Precancer and Cancer Gets Blurry
Some dermatologists argue that actinic keratosis is already a very early form of squamous cell carcinoma rather than a separate condition. The reason: under a microscope, the abnormal cell changes in actinic keratosis look similar to what’s seen in early skin cancer. Both conditions share the same type of DNA damage, specifically mutations caused by ultraviolet light hitting skin cells at the same genetic sites. The key difference is depth. Actinic keratosis stays in the outermost layer of skin (the epidermis), while squamous cell carcinoma invades deeper tissue.
The most widely accepted view treats actinic keratosis as a precancer that can progress into squamous cell carcinoma with continued UV exposure. Think of it as a warning signal rather than a diagnosis of cancer itself.
What Actinic Keratosis Looks and Feels Like
These spots are often easier to feel than to see. The hallmark is a rough, sandpapery patch of skin, usually less than an inch across. You might notice it when running your fingers over sun-exposed areas like the face, scalp, ears, forearms, or backs of the hands. The patches can be flat or slightly raised, and their color ranges from pink to red to brown. Some develop a hard, wart-like texture.
Itching, burning, and occasional crusting are common. Most actinic keratoses are painless, but discomfort doesn’t necessarily mean something worse is happening. What does raise concern is a spot that bleeds, ulcerates, becomes firm or thickened (a quality dermatologists call “induration”), grows rapidly, or exceeds one centimeter in size. These changes suggest the lesion may be progressing toward squamous cell carcinoma, and a biopsy is typically the next step.
The Odds of Progression
Not every actinic keratosis turns into cancer. In fact, many go away on their own. Studies show that 15% to 63% of individual lesions regress within a year without any treatment. However, the picture is less reassuring when you look at recurrence: among people whose spots cleared completely, up to 57% saw them come back.
For the lesions that don’t regress, about 10% eventually progress to squamous cell carcinoma. One study tracking over 6,600 patients found that the average time from a confirmed actinic keratosis to a confirmed squamous cell carcinoma at the same location was roughly 24.6 months. That two-year window is why dermatologists generally prefer treating these spots rather than watching and waiting, especially when someone has multiple lesions.
Field Cancerization: The Bigger Picture
A single actinic keratosis rarely exists in isolation. Years of sun exposure damage an entire area of skin, not just the one spot you can see. This concept, called field cancerization, means that the skin surrounding a visible lesion already contains cells with UV-related DNA changes that haven’t yet formed visible patches. It was first described in the 1950s when pathologists found abnormal cells in tissue that appeared completely normal to the naked eye.
This is why treatment sometimes targets the broader area rather than just individual spots. Treating only what’s visible can leave behind damaged cells that eventually produce new lesions or progress on their own.
How Actinic Keratosis Is Treated
Treatment falls into two broad categories: targeting individual spots or treating a wider field of damaged skin. For isolated or thick, stubborn lesions, the most common approach is cryotherapy (freezing with liquid nitrogen). It’s quick, performed in the office, and clears lesions at rates between 39% and 83% depending on technique and how long the freeze is applied. Curettage (scraping) and laser removal are other options for individual spots.
When you have several lesions spread across an area, field-directed therapy makes more sense. The most effective topical option is a prescription cream containing fluorouracil, a chemical that destroys abnormal skin cells while leaving healthy tissue largely intact. In one study of 150 patients, 92% achieved complete clearance with 4% fluorouracil cream, though about 11% experienced recurrence within a year. The treatment typically involves applying the cream daily for several weeks, during which the skin becomes red, raw, and sometimes painfully inflamed before healing with clearer skin underneath.
Other topical options include imiquimod, which stimulates the immune system to attack abnormal cells (complete clearance around 54%), and newer treatments like tirbanibulin, which received a strong recommendation from the American Academy of Dermatology in 2022. Photodynamic therapy, which uses a light-sensitizing solution followed by exposure to a specific wavelength of light, works particularly well for large areas or cosmetically sensitive spots like the face.
What Treatment Feels Like
Cryotherapy stings for a few seconds during the freeze and may leave a blister or scab that heals over one to two weeks. Topical creams cause the most dramatic visible reaction: your skin will look worse before it looks better, often turning intensely red, peeling, and crusting for the duration of treatment. This reaction is actually a sign the medication is working, destroying the damaged cells. Most people heal with improved skin texture within a few weeks of stopping the cream.
When a Biopsy Is Needed
Most actinic keratoses are diagnosed by appearance alone during a skin exam. A biopsy becomes necessary when a lesion shows signs that suggest it may have already crossed the line into squamous cell carcinoma: bleeding, ulceration, rapid growth, firmness, or a size greater than one centimeter. A spot that doesn’t respond to appropriate treatment also warrants a biopsy, since treatment resistance can indicate something more aggressive is present. Unusual-looking lesions that don’t fit the typical actinic keratosis appearance are also biopsied to rule out other diagnoses.
Reducing Your Risk Going Forward
UV protection is the single strongest recommendation from dermatology guidelines for managing actinic keratosis. That means consistent sunscreen use, protective clothing, and avoiding peak sun hours. This isn’t just about preventing new spots. Continued UV exposure is the mechanism that pushes existing actinic keratoses toward squamous cell carcinoma, so sun protection directly reduces the odds of progression. If you’ve already been diagnosed with actinic keratosis, regular skin checks become part of your routine, since having these lesions signals that your skin has accumulated significant UV damage and is at higher risk for future problems.